High Expression and Purification of Recombinant Human Serum Albumin from Pichia pastoris

Rong-De Qiu1, Shi-Yun Li, Jun-Gang Chen

  • 1Shanghai Institute of Biochemistry, the Chinese Academy of Science, Shanghai 200031, China. zhongyi@sunm.shcnc.ac.cn

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica Et Biophysica Sinica
|July 12, 2002
PubMed

Insights

Recombinant human serum albumin (rHSA) production in Pichia pastoris yielded 150 mg/L. This study details the successful purification of rHSA to electrophoretic purity using advanced chromatographic techniques.

Area of Science:

  • Biotechnology
  • Biochemistry
  • Molecular Biology

Background:

  • Recombinant human serum albumin (rHSA) is a valuable therapeutic protein.
  • Efficient and scalable production methods for rHSA are crucial for its widespread application.
  • Pichia pastoris is a well-established host for recombinant protein expression.

Purpose of the Study:

  • To optimize the expression of recombinant human serum albumin (rHSA) in Pichia pastoris.
  • To develop and implement a purification strategy for obtaining highly pure rHSA.
  • To achieve a high yield of electrophoretically pure rHSA for potential therapeutic use.

Main Methods:

  • Optimization of recombinant protein expression in Pichia pastoris.
  • Downstream processing involving hollow-fiber ultrafiltration for initial isolation.
  • Multi-step chromatography including Phenyl-Sepharose hydrophobic interaction chromatography and antibody-immunoadsorbent chromatography for purification.

Main Results:

  • Achieved an expression level of approximately 150 mg/L of rHSA in Pichia pastoris supernatant.
  • Successfully purified rHSA through a combination of ultrafiltration and chromatography.
  • Demonstrated electrophoretic purity of the final rHSA product.

Conclusions:

  • Pichia pastoris is an effective host for high-level production of recombinant human serum albumin.
  • The developed purification protocol effectively isolates and purifies rHSA to a high degree.
  • The optimized expression and purification process offers a viable method for producing therapeutic-grade rHSA.